PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · IEX Real-Time Price · USD
4.380
+0.530 (13.77%)
Mar 28, 2024, 10:48 AM EDT - Market open

PDS Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013
Net Income
-40.85-16.92-14.85-7-3.84-50.86-38.82-32.44-13.78-7.96
Depreciation & Amortization
0.240.250.180.10.070.180.10.050.030
Share-Based Compensation
5.24.070.433.740.876.185.312.91.30.26
Other Operating Activities
9.710.111.09-14.921.333.81.233.371.16-1.43
Operating Cash Flow
-25.71-12.49-13.15-18.07-1.57-40.7-32.19-21.75-9.72-8.04
Capital Expenditures
0000.280-0.19-0.69-1.31-0.88-0.14
Acquisitions
00029.11000000
Investing Cash Flow
00029.380-0.19-0.69-1.31-0.88-0.14
Share Issuance / Repurchase
10.0148.8929.830.751.4117.550.3186.0600
Debt Issued / Paid
24.55000-0.0259.312.472.910.08
Other Financing Activities
-0.27---0.1--0.5450.9913.5715.82
Financing Cash Flow
34.2948.8929.830.751.522.559.08139.5216.4715.9
Net Cash Flow
8.5836.416.6812.06-0.07-18.33-23.79116.465.877.72
Free Cash Flow
-25.71-12.49-13.15-17.8-1.57-40.89-32.88-23.06-10.6-8.18
Free Cash Flow Per Share
-0.90-0.49-0.79-3.66-0.47-26.90-22.78-57.02-125.56-96.91
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).